ESR1 and neoplasm: Risk factors such as age, body mass index (BMI), tumor size, progesterone receptor status (PR status), estrogen receptor status (ER status), human epidermal growth factor receptor-2 status (Her-2 status), and other clinical indicators have been identified in numerous previous studies as linked to ALN metastasis in breast carcinoma [9–11].